FTH
Faeth Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$19.99
+1.73%Next report
Analyst consensus
- Next report date
- Mar 29, 2027
- EPS estimate
- -$0.68
- Revenue estimate
- —
Latest reported
- Last report date
- Nov 3, 2026
- EPS actual
- -$0.79
- EPS estimate
- -$0.78
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -4.3%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $58
- PT range
- $56 – $60
- Analysts
- 2
2 Buy0 Hold0 Sell
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Nov 3, 2026 | -$0.78 | -$0.79 | Miss -1.07% | — |
| Aug 4, 2026 | -$2.64 | -$2.84 | Miss -7.58% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Apr 1, 2027